321 related articles for article (PubMed ID: 30975967)
1. Invasive fungal consecutive infections in a patient with acute myeloid leukaemia.
Safai Nodeh SR; Dehghan Manshadi SA; Jahanbin B; Khodaveisi S; Giasvand F; Seifi A; Salehi M
Niger J Clin Pract; 2019 Apr; 22(4):582-584. PubMed ID: 30975967
[TBL] [Abstract][Full Text] [Related]
2. Invasive mould infections in the ICU setting: complexities and solutions.
Bassetti M; Bouza E
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
[TBL] [Abstract][Full Text] [Related]
3. Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
Manzoor NF; Azim S; Fadoo Z
J Pak Med Assoc; 2010 Nov; 60(11):977-9. PubMed ID: 21375212
[TBL] [Abstract][Full Text] [Related]
4. Multiple small bowel perforations due to invasive aspergillosis in a patient with acute myeloid leukemia: case report and a systematic review of the literature.
Di Franco G; Tagliaferri E; Pieroni E; Benedetti E; Guadagni S; Palmeri M; Furbetta N; Campani D; Di Candio G; Petrini M; Mosca F; Morelli L
Infection; 2018 Jun; 46(3):317-324. PubMed ID: 29357049
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic administration of voriconazole with two different doses for invasive fungal infection in children and adolescents with acute myeloid leukemia.
Sano H; Kobayashi R; Hori D; Kishimoto K; Suzuki D; Yasuda K; Kobayashi K
J Microbiol Immunol Infect; 2018 Apr; 51(2):260-266. PubMed ID: 27329132
[TBL] [Abstract][Full Text] [Related]
6. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary aspergillosis in the neutropenic patient. Apropos of 4 cases].
Ben Othman T; Ben Lakhal B; Medini Manai Z; Ladeb S; M'Sadek F; Meddeb B; Ben Abid H; Bel Hadj Ali Z; Hafsia R; Ben Abdeladhim A; Hafsia A
Tunis Med; 1996 Nov; 74(11):493-500. PubMed ID: 9506113
[No Abstract] [Full Text] [Related]
8. Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
Pomares H; Arnan M; Sánchez-Ortega I; Sureda A; Duarte RF
Mycoses; 2016 Aug; 59(8):516-9. PubMed ID: 27027972
[TBL] [Abstract][Full Text] [Related]
9. The cost-utility analysis of antifungal prophylaxis for invasive fungal infections in acute myeloid leukaemia patients receiving chemotherapy: a study from a middle-income country.
Pungprasert T; Dhirachaikulpanich D; Phutthasakda W; Tantai N; Maneeon S; Nganthavee V; Atipas K; Tanpong S; Krithin S; Tanglitanon S; Jutidamrongphan W; Chayakulkeeree M; Srinonprasert V; Phikulsod P
J Hosp Infect; 2024 Mar; 145():118-128. PubMed ID: 38219835
[TBL] [Abstract][Full Text] [Related]
10. New pharmacological opportunities for the treatment of invasive mould diseases.
Ledoux MP; Toussaint E; Denis J; Herbrecht R
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i48-i58. PubMed ID: 28355467
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.
Floros L; Kuessner D; Posthumus J; Bagshaw E; Sjölin J
BMC Infect Dis; 2019 Feb; 19(1):134. PubMed ID: 30744563
[TBL] [Abstract][Full Text] [Related]
12. Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia.
Decembrino N; Zecca M; Tortorano AM; Mangione F; Lallitto F; Introzzi F; Bergami E; Marone P; Tamarozzi F; Cavanna C
New Microbiol; 2016 Jan; 39(1):65-9. PubMed ID: 26922988
[TBL] [Abstract][Full Text] [Related]
13. How We Approach Combination Antifungal Therapy for Invasive Aspergillosis and Mucormycosis in Transplant Recipients.
Haidar G; Singh N
Transplantation; 2018 Nov; 102(11):1815-1823. PubMed ID: 29975240
[TBL] [Abstract][Full Text] [Related]
14. Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country.
Korula A; Abraham A; Abubacker FN; Viswabandya A; Lakshmi KM; Abraham OC; Rupali P; Varghese GM; Michael JS; Srivastava A; Mathews V; George B
Mycoses; 2017 Oct; 60(10):686-691. PubMed ID: 28736936
[TBL] [Abstract][Full Text] [Related]
15. Typhlitis due to mucormycosis after chemotherapy in a patient with acute myeloid leukemia.
Yi HS; Sym SJ; Park J; Cho EK; Shin DB; Lee JH
Leuk Res; 2010 Jul; 34(7):e173-5. PubMed ID: 20074799
[No Abstract] [Full Text] [Related]
16. Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome.
Phillips K; Cirrone F; Ahuja T; Siegfried J; Papadopoulos J
J Oncol Pharm Pract; 2019 Mar; 25(2):398-403. PubMed ID: 30319061
[TBL] [Abstract][Full Text] [Related]
17. Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies.
Nosari A; Anghilieri M; Carrafiello G; Guffanti C; Marbello L; Montillo M; Muti G; Ribera S; Vanzulli A; Nichelatti M; Morra E
Haematologica; 2003 Dec; 88(12):1405-9. PubMed ID: 14687995
[TBL] [Abstract][Full Text] [Related]
18. Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
Oyake T; Kowata S; Murai K; Ito S; Akagi T; Kubo K; Sawada K; Ishida Y
Eur J Haematol; 2016 Jun; 96(6):602-9. PubMed ID: 26216048
[TBL] [Abstract][Full Text] [Related]
19. Management of Invasive Fungal Infections in Pediatric Acute Leukemia and the Appropriate Time for Restarting Chemotherapy.
Tüfekçi Ö; Yılmaz Bengoa Ş; Demir Yenigürbüz F; Şimşek E; Karapınar TH; İrken G; Ören H
Turk J Haematol; 2015 Dec; 32(4):329-37. PubMed ID: 25913290
[TBL] [Abstract][Full Text] [Related]
20. First case of proven invasive pulmonary infection due to Trichoderma longibrachiatum in a neutropenic patient with acute leukemia.
Sautour M; Chrétien ML; Valot S; Lafon I; Basmaciyan L; Legouge C; Verrier T; Gonssaud B; Abou-Hanna H; Dalle F; Caillot D
J Mycol Med; 2018 Dec; 28(4):659-662. PubMed ID: 30477694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
